Thomas SM - Search Results

1

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer.

Fridman JS, Caulder E, Hansbury M, Liu X, Yang G, Wang Q, Lo Y, Zhou BB, Pan M, Thomas SM, Grandis JR, Zhuo J, Yao W, Newton RC, Friedman SM, Scherle PA, Vaddi K. Fridman JS, et al. Among authors: thomas sm. Clin Cancer Res. 2007 Mar 15;13(6):1892-902. doi: 10.1158/1078-0432.CCR-06-2116. Clin Cancer Res. 2007. PMID: 17363546

2

Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.

Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Leeman-Neill RJ, et al. Among authors: thomas sm. Clin Cancer Res. 2010 May 1;16(9):2571-9. doi: 10.1158/1078-0432.CCR-10-0333. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388852 Free PMC article.

3

Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

Sen M, Joyce S, Panahandeh M, Li C, Thomas SM, Maxwell J, Wang L, Gooding WE, Johnson DE, Grandis JR. Sen M, et al. Among authors: thomas sm. Clin Cancer Res. 2012 Sep 15;18(18):4986-96. doi: 10.1158/1078-0432.CCR-12-0792. Epub 2012 Jul 23. Clin Cancer Res. 2012. PMID: 22825581 Free PMC article.

4

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

Thomas SM, Grandis JR. Thomas SM, et al. Cancer Treat Rev. 2004 May;30(3):255-68. doi: 10.1016/j.ctrv.2003.10.003. Cancer Treat Rev. 2004. PMID: 15059649 Review.

5

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.

Thomas SM, Zeng Q, Epperly MW, Gooding WE, Pastan I, Wang QC, Greenberger J, Grandis JR. Thomas SM, et al. Clin Cancer Res. 2004 Oct 15;10(20):7079-87. doi: 10.1158/1078-0432.CCR-04-0587. Clin Cancer Res. 2004. PMID: 15501988

6

Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.

Koppikar P, Choi SH, Egloff AM, Cai Q, Suzuki S, Freilino M, Nozawa H, Thomas SM, Gooding WE, Siegfried JM, Grandis JR. Koppikar P, et al. Among authors: thomas sm. Clin Cancer Res. 2008 Jul 1;14(13):4284-91. doi: 10.1158/1078-0432.CCR-07-5226. Clin Cancer Res. 2008. PMID: 18594011 Free PMC article.

7

Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Nozawa H, Howell G, Suzuki S, Zhang Q, Qi Y, Klein-Seetharaman J, Wells A, Grandis JR, Thomas SM. Nozawa H, et al. Among authors: thomas sm. Clin Cancer Res. 2008 Jul 1;14(13):4336-44. doi: 10.1158/1078-0432.CCR-07-4857. Clin Cancer Res. 2008. PMID: 18594017 Free PMC article.

8

HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.

Knowles LM, Stabile LP, Egloff AM, Rothstein ME, Thomas SM, Gubish CT, Lerner EC, Seethala RR, Suzuki S, Quesnelle KM, Morgan S, Ferris RL, Grandis JR, Siegfried JM. Knowles LM, et al. Among authors: thomas sm. Clin Cancer Res. 2009 Jun 1;15(11):3740-50. doi: 10.1158/1078-0432.CCR-08-3252. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470725 Free PMC article.

9

Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagy.

Zang Y, Thomas SM, Chan ET, Kirk CJ, Freilino ML, DeLancey HM, Grandis JR, Li C, Johnson DE. Zang Y, et al. Among authors: thomas sm. Clin Cancer Res. 2012 Oct 15;18(20):5639-49. doi: 10.1158/1078-0432.CCR-12-1213. Epub 2012 Aug 28. Clin Cancer Res. 2012. PMID: 22929803 Free PMC article.

10

Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

Shin DM, Zhang H, Saba NF, Chen AY, Nannapaneni S, Amin AR, Müller S, Lewis M, Sica G, Kono S, Brandes JC, Grist WJ, Moreno-Williams R, Beitler JJ, Thomas SM, Chen Z, Shin HJ, Grandis JR, Khuri FR, Chen ZG. Shin DM, et al. Among authors: thomas sm. Clin Cancer Res. 2013 Mar 1;19(5):1244-56. doi: 10.1158/1078-0432.CCR-12-3149. Epub 2013 Feb 19. Clin Cancer Res. 2013. PMID: 23422093 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

702 results

Search Page